22Nd Century Group (Nasdaq: Xxii) Acquires Gvb Biopharma, A Leading Hemp/Cannabis Company
Acquiring Company
22nd Century
Acquired Company
GVB Biopharma
BuffaloLas VegasManufacturingInformation TechnologyBiotechnologyAgriculture and FarmingMedia And EntertainmentHealth CareScience And EngineeringPrivacy And SecurityManufacturingAgriculture And FarmingDescription
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the acquisition of privately held GVB Biopharma. As a contract development and manufacturing organization (CDMO), GVB is believed to be one of the largest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide based on total tonnage.
Quick answer
22nd Century is acquiring GVB Biopharma, announced May 13, 2022. 22nd Century is based in Buffalo, New York, United States.
- How much did 22nd Century pay for GVB Biopharma?
- The deal value was not disclosed.
- What does 22nd Century do?
- 22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology.
- Where are 22nd Century and GVB Biopharma based?
- 22nd Century is based in Buffalo, New York, United States. GVB Biopharma is based in Las Vegas, Nevada, United States.
- Who are the decision-makers at 22nd Century?
- Fundz holds 1 contact at 22nd Century. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Media And Entertainment
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Halozyme Completes Antares Pharma Acquisition (May 24, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
- Regeneron Completes Acquisition Of Checkmate Pharmaceuticals (May 31, 2022)
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis (April 19, 2022)
- Regeneron To Acquire Checkmate Pharmaceuticals And Its Investigational Immune Activator For Potential Use In Multiple Tumor Types (April 19, 2022)
Who to call at 22nd Century, and when
When 22nd Century changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day 22nd Century raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 22nd Century, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 22nd Century. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 22nd Century makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired GVB Biopharma?
GVB Biopharma was acquired by 22nd Century, based in Buffalo. The deal was reported on May 13, 2022. 22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology. 22nd Century is publicly traded (XXII) and operates in Manufacturing.
When did 22nd Century acquire GVB Biopharma?
22nd Century's acquisition of GVB Biopharma was reported on May 13, 2022. 22nd Century Group, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does GVB Biopharma do?
Founded in 2016, GVB is one of the world’s leading innovators in hemp technology. It is privately held, operating in Manufacturing, and is based in Las Vegas.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.